However, cBioPortal reveals that, in the same cancer genome studies where STK11 is mutated or deleted, the PRKAA1 gene encoding α1 is often amplified, with the highest frequency (10–15%) also occurring in lung adenocarcinomas (Fig. 3B; note the preponderance of red bars). This evidence concerns the gene PRKAA1 and cancer.